LONDON, February 2, 2018 /PRNewswire/ --

Contract Detailing, Contract Non-Personal Promotion, Medical Education Services, Sample Management Services, Teledetailing Services, Edetailing Services

Report Details 

The global pharma contract sales market is expected to grow at a CAGR of 9.6% in the first half of the forecast period. The market is expected to grow at a CAGR of 7.9% from 2017-2028. The market is estimated at $5.48bn in 2017 and $9.48bn in 2023.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector. 

In this brand new 238-page report you will receive 88 tables and 64 figures- all unavailable elsewhere. 

The 238-page report provides clear detailed insight into the global pharma contract sales market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope 

• Global Pharma Contract Sales Market forecasts from 2018-2028

• Along with revenue prediction for the overall world market for pharma contract sales market, our investigation shows forecasts to 2028 for the following submarkets:
- Contract detailing (personal promotion/field sales)
- Contract non-personal promotion, with further sub-forecasting for teledetailing, eDetailing and others
- Medical education services
- Sample management services

• This report also breaks down the revenue forecast for pharma contract sales market by therapeutic segments:
- Cardiovascular disease
- Metabolic disorders
- Cancer treatment
- Other 

• This report provides individual revenue forecasts to 2028 for these regional and national markets:
- USA
- Japan
- Germany, UK, France, Italy and Spain (EU5 countries)
- China, India, Brazil and Russia (BRIC group)

• Our study discusses the SWOT and STEP factors of the global pharma contract sales market

• Our study discusses issues affecting the pharma contract sales industry and market from 2017:
- Outsourced and in-house sales reps - trends and emerging sales models, including multiple channels (multichannel marketing to medical professionals)
- Services CSOs offer and benefits to drug companies outsourcing medical sales
- Maturing brands and product launches, including flexibility in field sales teams
- Legislation and new market access requirements for pharma sales representatives 
- Changes to online marketing and potential for IT technologies Risk-sharing agreements
- Key account management (KAM) and medical science liaison (MSL)

• This report discusses the leading companies in pharma contract sales

Visiongain's study is intended for anyone requiring commercial analyses for the global pharma contract sales market. You find data, trends and predictions. 

Buy our report today Global Pharma Contract Sales Market 2018-2028: Contract Detailing, Contract Non-Personal Promotion, Medical Education Services, Sample Management Services, Teledetailing Services, Edetailing Services.

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com (+44-(0)-20-7336-6100) or refer to our website: https://www.visiongain.com/Report/2115/Global-Pharma-Contract-Sales-Market-2018-2028

Leading Companies and Organisations Mentioned

AbbVie

Actavis

Actelion Pharmaceuticals

Addison Whitney

Adheris Health

Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM)

Agência Nacional de Vigilância Sanitária (ANVISA)

Akrikhin

Alexion

Allergan

Amgen

Apple

Aquilant Specialist Healthcare Services

Arbor Pharmaceuticals Ireland

Arena Pharmaceuticals

Ashfield Commercial and Medical Services

Association of the British Pharmaceutical Industry (ABPI)

AstraZeneca

Bayer Healthcare

Biogaran

Biogaran

Boehringer Ingelheim

Brazilian Ministério da Saúde (Ministry of Health)

Bristol Myers Squibb

Cegedim

Celesio

Celgene

Centers of Medicare and Medicaid Services (CMS)

Chinese Ministry of Health

CMIC

Daiichi Sankyo

Dayarn Pharma

Dendreon

Depomed

DottNet.it

Drug Safety Alliance (DSA)

Eisai

Eli Lilly and Co.

Encore Health Resources

Endo Pharmaceuticals

European Commission (EC)

European Federation of Pharmaceutical Industries and Associations (EFPIA)

European Medicines Agency (EMA)

European Promotional Product Association (EPPA)

Expansis

Food and Drugs Administration (FDA)

Galliard

German FSA

Gesamtverband der Werbeartikel Wirtschaft e.V. (GWW)

Go! Healthcare Marketing

Google

Gralise

Group DCA

GSK

Haymarket Media

Hospira

In2Focus

Innovex

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesenis (IQWiG)

International Federation of Pharmaceutical Manufacturers & Associations

Interpace BioPharma

inVentiv Health

Invida

J. Knipper and Company

Janssen Biotech

Japanese Pharmaceutical Manufacturers Association (JPMA)

Kadrige

Kare Pharma International

Knowledge Point360

L'Agenzia Italiana del Farmaco (AIFA)

Liberty Lane Partners

Lupin

Marvecs

Medical Communications Group (MCG)

Medical Council of India (MCI)

MediMedia Health

Menarini Asia-Pacific

Merck & Co.

Merqurio Pharma

Merrimack

Millennium Pharmaceuticals

Ministère des Affaires Sociales et de la Santé

National Health Service (NHS)

National Institute for Health and Care Excellence (NICE)

Navicor

Neurocrine Biosciences

Neurocrine Biosciences.

NovaMed

Novartis

Novella Clinical

Novo Nordisk

OnCall LLC

Organization of Pharmaceutical Producers of India (OPPI)

Otsuka

PALIO

PDI

Pharmaceutical Research and Manufacturers of America (PhRMA)

Pharmagistics

Pharmexx

Polpharma

Promius Pharma

Publicis Healthcare Communications Group

Publicis Touchpoint

Qforma

Quantia

QuintilesIMS

Ramco Import Export

Roche

Salesforce.com

Sanofi

Schering-Plough

Sermo

Sharp Packaging Services

Sinclair IS Pharma

Smithkline Beecham

Sofip (Société de Franchise pour l'Information Pharmaceutique)

StayinFront

Symplmed Pharmaceuticals

Synopia Rx

Taiho Oncology

Takeda

Tardis Medical

Temasek Holdings

Tesaro

Teva Pharmaceutical Industries

The Dartmouth Institute for Health Policy and Clinical Practice

The Medicines Company

The Organization of Pharmaceutical Producers of India (OPPI)

Thomas H. Lee Partners

Transgenomic    

UDG Healthcare

UK Department of Health

United Therapeutics

Univadis

US Center for Disease Prevention and Control (CDC)

US Congressional Budget Office (CBO)

US Supreme Court

Veeva Systems

Vivus

World Health Organisation (WHO)

ZS Associates

Zuellig Pharma

To see a report overview please email Sara Peerun on sara.peerun@visiongain.com

SOURCE Visiongain